March 28, 2024 | AAPL, Daily JAM, Jubak Picks, Morning Briefing, Short Term, Top 50 Stocks |
Apple is likely to take its shareholders on an even wilder ride in the next six months than they’ve been on since the December all-time high at $199.62. The end result, I think is likely to be a renewed rally beginning in the fall–if you can either hold on through the volatility until then or see your way clear to timing when to buy and sell.
March 26, 2024 | Daily JAM, Dividend Income, EQNR, Special Reports, Volatility |
Equinor (EQNR) is Pick #4 in my Special Report A New World for Dividend Investors. I posted this pick in my long Special Report post. But I wanted to flag it here as well so no one wouldl miss the pick. Dividend Pick #4: Equinor (EQNR)
March 26, 2024 | Daily JAM, Jubak Picks, LLY, Mid Term, Morning Briefing, NVO, Stock Alerts, VKTX |
First, it was Viking Therapeutics (VKTX) on the attack with trial results that shows its GLP-1 dibetes/weight loss drug out performing current leader of the pack drugs fro Novo Nordisk (NVO) and Eli Lilly (LLY). On the news Viking soared.
Then Novo Nordisk struct back with data of its own showing progress on an oral formulation of its rugs. (All existing GLP-1 drugs are delivered by injection.) That cratered Viking Shares. Now, March 26, Viking has released new Phase 1 trial data from a multiple ascending dose study of the oral version of VK2735, a dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors.
March 25, 2024 | Daily JAM, Dividend Income, PFE, Special Reports |
Bookkeeping. I added Pfizer as the first of 10 picks in my Special Report A New World for Dividends. You can find this write up on that long Special Reports post. But I want to make no one misses that pick and update.
March 25, 2024 | Daily JAM, DLR, Videos |
Today’s Quick Pick is Digital Realty Trust (DLR). This dividend stock, currently pays at 3.46% (previously a bit higher) but the stock has done well on price appreciation too. This is a different way to play the AI boom–by investing in the data center realty space. Data centers are the hottest part of the real estate market at the moment and AI data center capacity is likely to double in the next 6-10 years. Digital Realty has about 300 data centers worldwide with 40 million square feet of rentable space. They recently made a deal with Brookfield in order to raise more capital to build out more facilities and expand their business. The stock is up only about 5.6% year to date which isn’t great if you’re looking at the AI boom. It is up 43% over the last year but recent guidance from the company disappointed investors. The “meh” stock performance recently marks a good time to get in on a stock that has good dividends and a potential for capital appreciation when growth picks up again. The stock has been a member of my Dividend Portfolio since March 16, 2019. The shares are up 161% since then as of March 25.Â
March 23, 2024 | ADBE, Daily JAM, MRNA, Short Term |
The week will bring lots of important news on inflation and on the auto sectors and from Adobe on developments in AI. With some strange wrinkles in timing due to the short Good Friday schedule.
March 19, 2024 | Daily JAM, Dividend Income, EQNR, Jubak Picks, Mid Term, Special Reports, Top 50 Stocks, V |
Let’s say you’re a dividend income investor. You need cash income in retirement. Or you want your portfolio to generate cash now so you can invest in new opportunities. Or you just want the extra safety and lower risk that owning a stock with a substantial dividend can bring. Whatever your reasons–and I can think of a lot more–this is a particularly challenging financial market for dividend income investors.But I do think there are strategies dividend income investors can successfully pursue even in this challenging market. In the rest of this Special Report I’m going to explain the three ways I think you should be thinking about dividend income investing in this market. And then I’m going to give you 10 dividend stocks that I think are especially well-suited to producing income (and price appreciation, which is always nice even if you’re an income investor) in this market environment. First pick just posted–Pfizer
March 19, 2024 | Daily JAM, KBWB, Mid Term, Millennial, Videos |
Today’s Quick Pick is Lithium Americas (LAC). Lithium Americas is an American lithium producer, with a big deposit in Thacker Pass that has been going through litigation and delays while struggling to get enough financing with lithium prices down. We’ll likely see a bottom of lithium prices in the second half of 2024 or early 2025, so this is a good time to be getting in near the bottom. Lithium Americas signed a contract with General Motors agreeing that GM would take all the lithium they can produce, the question is, Can they produce it? Recently, the Department of Energy announced they’ll be lending Lithium Americas $2.3 billion to move forward with their processing facility. At the moment, China controls nearly all of the processing facilities for lithium globally and this investment will allow for domestic processing. This loan will cover all their capital costs and enable them to start production. The stock is moving upward, with shares around $6.50 per share. The recent rally has brought the stock back up to the price from December 2023, and the Wall Street consensus is that the stock may hit $11.50 in a year. While that prediction may be a bit ambitious, I think it’s likely we’ll see it reach $9-10, up about a third once they start to actually produce lithium in conjunction with lithium prices going up.
March 14, 2024 | Daily JAM, Jubak Picks, NVDA, QCOM, Top 50 Stocks, Videos |
Today’s Hot Button Moves NOW video is AI Woodstock. Nvidia’s big AI update on March 18 has been dubbed “AI Woodstock” by Bank of America. Nvidia will update its pipeline and prospects for new projects and report on where it sees the AI market going. It will likely create volatility throughout the AI sector as investors try to get out ahead of the company’s projections. Tuesday, Bank of America raised its target price for Nvidia from $925 to $1100 and upped its estimate of the size of the AI accelerator market from under $250 billion to $250-500 billion in 3-5 years. This wide gap in both market size and time makes me a little nervous, but for now we can focus on the next few days. Nvidia will be discussing its new B1000 and N100 chips, ethernet switches, and AI at the Edge for PCs and smartphones. Keep an eye on stocks like Broadcom (AVGO), Qualcomm (QCOM) and Super Micro Computer (SMCI) for reaction to this news. The volatility in the reaction could open up a good place to get in on these AI stocks.
March 12, 2024 | Daily JAM, Jubak Picks, QCOM, Stock Alerts, Videos |
Today’s Quick Pick is Qualcomm, (QCOM). I always look for product momentum in technology stocks, and Qualcomm’s pipeline is very promising. The company reported a good first quarter for 2024 but I’m focused on growth for their Snapdragon chip which is used in cell phones, cars, and the internet of things. Qualcomm has recently renewed its chip agreements with Apple and Samsung. Samsung’s Galaxy 24 is the first cell phone to include AI technology powered by Snapdragon and sales are up 13% year over year from 2023 and 47% from 2024. It’s likely more companies will be looking to add AI to their phones and I think Qualcomm has a leading position in that market. A new Snapdragon product, X-Elite, will put AI on PCs and is coming out this year. In 2023 the Snapdragon chip was also installed in infotainment modules for 75 new car models and the company’s automotive revenue is up about 12% this quarter. The Internet of Things is growing more slowly but is still growing. Morningstar says the stock is trading at a 22% premium, but I find that to be very, very conservative. While this stock isn’t a bargain at the moment this is a decent time to get in on an AI stock with promising pipeline momentum, and I don’t see it being more reasonable any time soon. I added Qualcomm to my Jubak’s Picks Portfolio on January 15, 2024. The position is up 23.5% since then as of the close on March 12.
March 11, 2024 | AAPL, Daily JAM, GOOG, Top 50 Stocks, Videos |
Today’s video is The Magnificent Five? The Magnificent Seven were the main drivers of market success at the end of 2023 and the beginning of 2024. But what happens when the Magnificent Seven are more like a magnificent Five, or even four? The original Magnificent Seven included Apple, Amazon, Meta Platforms, Microsoft, Alphabet (Google), Nvidia, and Tesla. Both Tesla and Apple have taken major hits largely due to problems with China. China’s regulations have made it harder to sell Apple products in the country in the government’s effort to push domestic goods. Apple sales in China are down 16-17%. in the first six weeks of 2024. This, alongside a Wall Street perception that Apple is behind in AI technology, has brought Apple shares down 12% for 2024. As for Tesla, China is producing massive numbers of cheaper electric vehicles that are increasingly exported globally (with the exception of the United States where high tariffs on Chinese electric vehicles limit sales) leaving Tesla down 25% in 2024. Google is also down 5% year to date though it may be too soon to write Alphabet off as “not magnificent” just yet. Both Apple and Tesla are no longer pacing the market and are indeed lagging. Bad thing? Good thing? I’d vote for “good thing.” The rally is beginning to spread out from a handful of big names. The only thing that makes me a bit wary is that so many investors are hoping to make money on speculative moves while the market is moving sideways. Those moves could cause volatility in a market that is otherwise likely to stay steady until we get big news from the Federal Reserve on interest rate cuts in June or so.
March 7, 2024 | Daily JAM, Jubak Picks, LLY, NVO |
Yes, I know this is my third post (plus video) on diabetes/weight-loss drug leader Novo Nordisk (NVO) in three weeks. But the company keeps pumping out research updates that keep powering the stock higher. Think of this as a momentum stock where the momentum comes from the R&D pipeline and not moves in the share price. (The last post was https://jubakam.com/another-reason-t…-success-for-glp/) Today, the company reported early results for a next-generation oral weight loss drug called amycretin, showing a 13.1% weight loss after 12 weeks. That’s a bigger weight-loss than either Novo Nordisk’s own Wegovy or Eli Lilly’s (LLY) competing drug Zepbound. Shares of Novo Nordisk were up 8.9% today to $135.85. I added them to my Jubak’s Picks Portfolio on February 20. The position is up 11.91% since then.